Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares
Dec 06, 2024•over 1 year ago
Contract Type
contract
BiotechnologyHealth CareMedicalMedical Device
Description
Profound Medical Corp. has priced an underwritten public offering of 4,666,700 common shares at a public offering price of US$7.50 per Common Share, with expected gross proceeds of approximately US$35 million. The net proceeds will be used to fund the commercialization and development of the TULSA-PRO® system in the United States and globally, as well as for working capital and general corporate purposes.
Related People
Suggested for you
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months